Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Ovid Therapeutics (OVID) Receivables - Other (2020 - 2021)

Ovid Therapeutics (OVID) has disclosed Receivables - Other for 2 consecutive years, with $1.0 million as the latest value for Q1 2021.

  • For the quarter ending Q1 2021, Receivables - Other rose 173.56% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Mar 2021, up 173.56%, and an annual FY2020 reading of $141763.0, changed N/A over the prior year.
  • Receivables - Other was $1.0 million for Q1 2021 at Ovid Therapeutics, up from $141763.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.0 million in Q1 2021 and bottomed at $141763.0 in Q4 2020.